Notice2024-24925
Meeting of the Lead Exposure and Prevention Advisory Committee
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 25, 2024
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention announces the following meeting for the Lead Exposure and Prevention Advisory Committee (LEPAC). This virtual meeting is open to the public. Advance registration by December 4, 2024, is needed to receive the information to join the meeting. The registration link is provided in the addresses section below.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 207 (Friday, October 25, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 207 (Friday, October 25, 2024)]
[Notices]
[Page 85216]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-24925]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Lead Exposure and Prevention Advisory Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention announces the following
meeting for the Lead Exposure and Prevention Advisory Committee
(LEPAC). This virtual meeting is open to the public. Advance
registration by December 4, 2024, is needed to receive the information
to join the meeting. The registration link is provided in the addresses
section below.
DATES: The meeting will be held on December 11, 2024 from 11 a.m. to 5
p.m., EST.
ADDRESSES: Register in advance <a href="https://events.gcc.teams.microsoft.com/event/0e538aa3-bc82-43e9-89ee-d997b498cfe6@9ce70869-60db-44fd-abe8-d2767077fc8f">https://events.gcc.teams.microsoft.com/event/0e538aa3-bc82-43e9-89ee-d997b498cfe6@9ce70869-60db-44fd-abe8-d2767077fc8f</a> to receive information to join the meeting.
FOR FURTHER INFORMATION CONTACT: Paul Allwood, Ph.D., M.P.H.,
Designated Federal Officer, National Center for Environmental Health,
Centers for Disease Control and Prevention, 4770 Buford Highway,
Atlanta, Georgia 30341, Telephone: 770-488-6774; Email: <a href="/cdn-cgi/l/email-protection#4e020b1e0f0d0e2d2a2d60292138"><span class="__cf_email__" data-cfemail="a2eee7f2e3e1e2c1c6c18cc5cdd4">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Background: The Lead Exposure and Prevention Advisory Committee was
established under Section 2203 of Public Law 114-322, the Water
Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j-21,
Registry for Lead Exposure and Prevention Advisory Committee.
Purpose: The LEPAC is charged with providing advice and guidance to
the Secretary, Department of Health and Human Services (HHS), and the
Director, CDC and Administrator, ATSDR, on (1) reviewing Federal
programs and services available to individual communities exposed to
lead; (2) reviewing current research on lead exposure to identify
additional research needs; (3) reviewing and identifying best
practices, or the need for best practices regarding lead screening and
the prevention of lead poisoning; (4) identifying effective services,
including services relating to healthcare, education, and nutrition for
individuals and communities affected by lead exposure and lead
poisoning, including in consultation with, as appropriate, the lead
exposure registry as established in Section 2203(b) of Public Law 114-
322; and (5) undertaking any other review or activities that the
Secretary determines to be appropriate.
Matters to be Considered: The agenda will include presentations and
discussions on the following topics: vote on the 2023 annual LEPAC
report, report from the Preventing Lead Exposure in Adults workgroup,
lead related updates from the LEPAC members, local perspective on
improving blood lead testing, blood lead testing strategies. Agenda
items are subject to change as priorities dictate.
Public Participation
Oral Public Comment: The public comment period is scheduled on
December 11, 2024, from 12:30 p.m. until 12:50 p.m., EST. Individuals
wishing to make a comment during the public comment period, please
email your name, organization, and phone number by November 25, 2024,
to <a href="/cdn-cgi/l/email-protection#a7ebe2f7e6e4e7c4c3c489c0c8d1"><span class="__cf_email__" data-cfemail="58141d08191b183b3c3b763f372e">[email protected]</span></a>.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-24925 Filed 10-24-24; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 25, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.